EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

High Fracture Risk of Femoral Bone Metastasis Treated with Palliative Radiotherapy in Recent Years

Kenji Makita, Hidehiro Hojo, Hidekazu Oyoshi iD, Takeshi Fujisawa, Masaki Nakamura iD, Gyo Uchida, Yume Koike, Yuzheng Zhou, Kento Tomizawa, Keiko Fukushi, Sadamoto Zenda

Current Oncology · 2024

DOI: 10.3390/curroncol31120549 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Current Oncology, 2024. Verfasst von Kenji Makita und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, National Cancer Center Hospital East, Kashiwa 277-8577, Chiba, Japan. Hauptthemen laut MEDLINE: Femoral Neoplasms, Femoral Fractures, Palliative Care, Radiotherapy. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: JSPS KAKENHI.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bone-modifying agents (BMAs) have been widely used to reduce skeletal-related events, including pathological fractures. Herein, we aimed to clarify the incidence of pathological fractures caused by high-risk femoral bone metastases after palliative radiotherapy (RT) in the BMA era and evaluate the necessity of prophylactic surgical stabilization. We assessed 90 patients with high-risk femoral bone metastases, indicated by Mirels’ scores ≥ 8, without pathological fractures and surgical fixations, who received palliative RT at our institution between January 2009 and December 2018. Pathological fracture incidence was analyzed using the Kaplan–Meier method and was 22.8% and 31.0% at 2 and 6 months, respectively. Pathological fractures were caused by 17 of 65 lesions (26.2%) and 9 of 25 lesions (36.0%) in patients who received BMAs and those who did not, respectively (p = 0.44). Additionally, 17 of 42 lesions (40.5%) and 9 of 48 lesions (18.8%) with axial cortical involvement ≥30 and

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Femoral NeoplasmsFemoral FracturesPalliative CareRadiotherapyFractures, SpontaneousRetrospective StudiesIncidenceProphylactic Surgical ProceduresOrthopedic Fixation DevicesFracture FixationBone Density Conservation AgentsChi-Square DistributionDenosumabZoledronic AcidChemopreventionHumansMaleFemaleAdultMiddle AgedAgedAged, 80 and overKaplan-Meier EstimateRisk Factors

Stichwörter der Autor:innen

bone metastasisfemoral bonepalliativepathological fractureradiotherapy

Substanzen

Bone Density Conservation AgentsDenosumabZoledronic Acid

Autor:innen und Institutionen

  • Department of Radiation Oncology, National Cancer Center Hospital East, Kashiwa 277-8577, Chiba, Japan.
  • Department of Radiation Oncology, National Hospital Organization Shikoku Cancer Center, Matsuyama 791-0280, Ehime, Japan.

ORCID-Profile: Hidekazu Oyoshi, Masaki Nakamura

Förderung

  • JSPS KAKENHI

Zitieren

APA

Makita, K., Hojo, H., Oyoshi, H., Fujisawa, T., Nakamura, M., Uchida, G., Koike, Y., Zhou, Y., Tomizawa, K., Fukushi, K., & Zenda, S. (2024). High Fracture Risk of Femoral Bone Metastasis Treated with Palliative Radiotherapy in Recent Years. Current Oncology. https://doi.org/10.3390/curroncol31120549

Vancouver

Makita K, Hojo H, Oyoshi H, Fujisawa T, Nakamura M, Uchida G, et al. High Fracture Risk of Femoral Bone Metastasis Treated with Palliative Radiotherapy in Recent Years. Current Oncology. 2024. doi:10.3390/curroncol31120549

BibTeX
@article{Makita2024,
  author = {Makita, Kenji and Hojo, Hidehiro and Oyoshi, Hidekazu and Fujisawa, Takeshi and Nakamura, Masaki and Uchida, Gyo and Koike, Yume and Zhou, Yuzheng and Tomizawa, Kento and Fukushi, Keiko and Zenda, Sadamoto},
  title = {High Fracture Risk of Femoral Bone Metastasis Treated with Palliative Radiotherapy in Recent Years},
  journal = {Current Oncology},
  year = {2024},
  doi = {10.3390/curroncol31120549}
}
Kostenlos starten →